IX1 Analyst Ratings
Moderate Buy
4 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IX1 Stock 12 Month Forecast
Average Price Target
$566.52
| Highest Price Target$648.10 | Average Price Target$566.52 | Lowest Price Target$515.26 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
―
Buy
―
Reiterated
07/07/26
Bank of America Securities
CHF531.36
Hold
―
Reiterated
07/07/26
Stifel Nicolaus
CHF543.44
Buy
―
Reiterated
05/06/26
Jefferies
CHF637.64
Buy
―
Reiterated
05/06/26
Morgan Stanley
CHF615.9→CHF648.1
Buy
―
Assigned
05/05/26
UBS
CHF587.72→CHF515.26
Hold
―
Assigned
04/28/26
Citi
CHF523.31
Hold
―
Initiated
04/16/26
Piper Sandler
CHF623.95→CHF603.82
Hold
―
Reiterated
02/09/26
Barclays
CHF684.33→CHF644.08
Buy
―
Reiterated
02/05/26
BTIG
CHF668.23→CHF644.08
Buy
―
Reiterated
02/03/26
J.P. Morgan
CHF623.95
Buy
―
Reiterated
11/03/25
Leerink Partners
CHF599.8→CHF632
Buy
―
Reiterated
11/03/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
―
Buy
―
Reiterated
07/07/26
Bank of America Securities
CHF531.36
Hold
―
Reiterated
07/07/26
Stifel Nicolaus
CHF543.44
Buy
―
Reiterated
05/06/26
Jefferies
CHF637.64
Buy
―
Reiterated
05/06/26
Morgan Stanley
CHF615.9→CHF648.1
Buy
―
Assigned
05/05/26
UBS
CHF587.72→CHF515.26
Hold
―
Assigned
04/28/26
Citi
CHF523.31
Hold
―
Initiated
04/16/26
Piper Sandler
CHF623.95→CHF603.82
Hold
―
Reiterated
02/09/26
Barclays
CHF684.33→CHF644.08
Buy
―
Reiterated
02/05/26
BTIG
CHF668.23→CHF644.08
Buy
―
Reiterated
02/03/26
J.P. Morgan
CHF623.95
Buy
―
Reiterated
11/03/25
Leerink Partners
CHF599.8→CHF632
Buy
―
Reiterated
11/03/25
Best Analysts Covering Idexx Laboratories
3 Months
Success Rate
7/9 ratings generated profit
Average Return
+7.60%
Copying Daniel Clark's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +7.60% per trade.
1 Year
Success Rate
26/34 ratings generated profit
Average Return
+26.37%
Copying Jonathan Block's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +26.37% per trade.
2 Years
Success Rate
25/34 ratings generated profit
Average Return
+57.46%
Copying Jonathan Block's trades and holding each position for 2 Years would result in 73.53% of your transactions generating a profit, with an average return of +57.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IX1 Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
9
8
6
5
5
Hold
7
10
6
5
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
18
12
10
7
Each month's total comprises the sum of three months' worth of ratings.
IX1 Financial Forecast
IX1 Stock Forecast FAQ
What is CH:IX1’s average 12-month price target, according to analysts?
Based on analyst ratings, Idexx Laboratories’s 12-month average price target is 566.52.
What is CH:IX1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:IX1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Idexx Laboratories a Buy, Sell or Hold?
Idexx Laboratories has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 3 hold ratings and 0 sell ratings.
What is Idexx Laboratories’s share price target?
The average share price target for Idexx Laboratories is 566.52. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $648.10 ,and the lowest forecast is $515.26. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is $648.10 ,and the lowest forecast is $515.26. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Idexx Laboratories?
Idexx Laboratories’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of Idexx Laboratories?
To buy shares of CH:IX1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.